Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039781 | SCV000063470 | likely benign | not specified | 2012-04-12 | criteria provided, single submitter | clinical testing | Asn436Asn in Exon 10 of MYLK2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 1/7020 European Ame rican chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). Asn436Asn in exon 10 of MYLK2 (allele frequ ency = 1/7020) ** |
Gene |
RCV000039781 | SCV000170572 | benign | not specified | 2014-05-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001089240 | SCV001003882 | likely benign | Hypertrophic cardiomyopathy 1 | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381317 | SCV002689976 | likely benign | Inborn genetic diseases | 2022-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003904950 | SCV004718914 | likely benign | MYLK2-related condition | 2023-12-12 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000863252 | SCV001959639 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000863252 | SCV001967294 | likely benign | not provided | no assertion criteria provided | clinical testing |